Docosahexaenoic- and eicosapentaenoic acid-bound lysophospholipids are more effective in suppressing angiogenesis than conjugated docosahexaenoic acid

Journal of Oleo Science

Volumn 61, Issue 8, 2012, Pages 427-432

  Tsushima, Tadahiro ^a   Matsubara, Kiminori ^b   Ohkubo, Takeshi ^c   Inoue, Yoshikazu ^d   Takahashi, Koretaro ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c NOF Corporation   (Japan)

^d Lipid Lab   (Japan)

Author keywords

Angiogenesis; Lysophospholipids; Omega 3; Phospholipids

Indexed keywords

ANGIOGENESIS; ANTI-ANGIOGENIC ACTIVITY; ARTERY TISSUES; COLON CANCER; CULTURE MEDIUM; DOCOSAHEXAENOIC ACID; EFFECTIVE SUPPRESSION; HUMAN UMBILICAL CORD; LIPOZYME; LYSOPHOSPHOLIPIDS; MOLECULAR SPECIES; OMEGA-3; OMEGA-3-FATTY ACIDS; PARTIAL HYDROLYSIS;

DISEASES; ENDOTHELIAL CELLS; HYDROLYSIS; MOLECULAR STRUCTURE; RATS; TISSUE; UNSATURATED FATTY ACIDS;

PHOSPHOLIPIDS;

DOCOSAHEXAENOIC ACID; DRUG DERIVATIVE; ICOSAPENTAENOIC ACID; LYSOPHOSPHATIDYLCHOLINE; LYSOPHOSPHOLIPID; PHOSPHATIDYLCHOLINE;

ANGIOGENESIS; ANIMAL; AORTA; ARTICLE; CELL MOTION; CEPHALOPOD; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; HUMAN; IN VITRO STUDY; MALE; NEOVASCULARIZATION (PATHOLOGY); RAT; SWINE; UMBILICAL VEIN ENDOTHELIAL CELL; WISTAR RAT;

ANIMALS; AORTA; CELL MOVEMENT; DECAPODIFORMES; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LYSOPHOSPHATIDYLCHOLINES; LYSOPHOSPHOLIPIDS; MALE; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHATIDYLCHOLINES; RATS; RATS, WISTAR; SUS SCROFA;

EID: 84869032234     PISSN: 13458957     EISSN: 13473352     Source Type: Journal    
DOI: 10.5650/jos.61.427     Document Type: Article

References (15)

1. Kim, K. J.; Li, B.; Winer, J.; Armanini, M.; Gillett, N.; Phillips, H. S.; Ferrara, N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature 362, 841-844(1993).
2. Rama, D. J.; William, F. M.; Joan, W. M. Age-related macular degeneration. N. Engl. J. Med. 358, 2606-2617(2008).
3. Tsuzuki, T.; Shibata, A.; Kawakami, Y.; Nakagaya, K.; Miyazawa, T. Conjugated eicosapentaenoic acid inhibits vascular endothelial growth factor-induced angiogenesis by suppressing the migration of human umbilical vein endothelial cells. J. Nutri. 137, 641-646 (2007).
4. Tsuzuki, T.; Shibata, A.; Kawakami, Y.; Nakagaya, K.; Miyazawa, T. Anti-angiogenic effects of conjugated docosahexaenoic acid in vitro and in vivo. Biosci. Biotechnol. Biochem. 71, 1902-1910(2007).
5. Murakawa, K.; Fukunaga, K.; Tanouchi, M.; Hosokawa, M.; Hossain, Z.; Takahashi, K. Therapy of myeloma in vivo using marine phospholipid in combination with Agaricus blazei Muril as an immune respond activator, J. Oleo Sci. 56, 179-188(2007).
6. Hossain, Z.; Fukunaga, K.; Tanouchi, M.; Takahashi, K. Chitosan and marine phospholipids reduce matrix metalloproteinase activity in myeloma SP2 tumor-bearing mice. Eur. J. Lipid Sci. Technol. 111, 877-889 (2009).
7. Fujimoto, A.; Sasaki, J.; Hosokawa, M.; Takahashi, K. Fibrosarcoma May Be Suppressed by Liposomal sn-2 DHA Inserted Phospholipid Therapy. in Essential Fatty Acids and Eicosanoids(Huang, Y.-S., Lin, S.-J. and Huang, P.-C., eds), AOCS Press, Champaign, pp. 290-295(2003).
8. Bligh, E. G.; Dyer, W. J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37: 911-917(1959).
9. Ono, M.; Hosokawa, M.; Inoue, Y.; Takahashi, K. Concentration of docosahexaenoic acid-containing phospholipid through Lipozyme IM-mediated Hydrolysis. J. Jpn. Oil Chem. Soc. 46, 867-872(1997).
10. Ono, M.; Hosokawa, M.; Inoue, Y.; Takahashi, K. Water activity-adjusted enzymatic partial hydrolysis of phospholipids to concentrate polyunsaturated fatty acids. J. Am. Oil Chem. Soc. 74, 1415-1417(1997).
11. Mori, M. et al. Capillary growth from reversed rat aortic segments cultured in collagen gel. Acta. Pathol. Jpn. 38, 1503-1512(1988).
12. Kawasaki, S.; Mori, M.; Awai.; M. Capillary growth of rat aortic segments cultured in collagen gel without serum. Acta. Pathol. Jpn. 39, 712-718(1989).
13. Kim, K. S.; Hong, Y. K.; Joe, Y. A.; Lee, Y.; Shin, J. y.; Park, H. E.; Lee, I. H.; Lee, S. Y.; Kang, D. K.; Chang, S. I. Anti-angiogenic activity of the recombinant kringle domain of urokinase and its specific entry into endothelial cells. J. Biol. Chem. 278, 11449-11456(2003).
14. Eliceiri, B. P.; Klemke, R.; Strömblad, S.; and David A. Cheresh Integrin αvβ3 Requirement for Sustained Mitogen-activated Protein Kinase Activity during Angiogenesis. J. Cell Biol. 140, 1255-1263(1998).
15. Tsuzuki, T. Conjugated fatty acids: the relationship between oxidative stability and physiological activities. J. Miyagi Univ. Sch. Food Agri. Environ. Sci. 1, 83-88 (2006).